Oxford BioMedica CEO To Hire More People, Expects More Deals Following Gene Therapy Pact With Axovant

 
• By Sten Stovall
  
Parkinsons
Duo Aim To Develop And Commercialize OXB-102 Using Oxford BioMedica's LentiVector Platform • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business